In this VASCERN Exchange Program interview, we are thrilled to interview Dr. Guido Giacalone and Dr. Florence Belva from the AZ Sint-Maarten, Mechelen, Belgium. Dr. Guido Giacalone and Dr. Florence Belva are members of the Pediatric and Primary Lymphedema Working Group (PPL-WG). In this article, they share what were their…
Mentors and educators, experts in the field, are available online to answer your questions and to support you during your journey in this #EJPRD MOOC until December 3rd, 2022. Take the opportunity to interact with them! ℹ️ https://www.ejprarediseases.org/upcoming-update-on-mooc-diagnosis-rare-diseases-from-the-clinic-to-research-and-back/
The Hereditary Hemorrhagic Telangiectasia Working Group (HHT-WG) has published an article titled European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)? in the European Journal of Medical Genetics as part of the VASCERN Special Issue. It is co-authored by members, collaborating experts, and the ePAG…
The European Joint Programme on Rare Diseases (EJP RD) is glad to announce that the last round for the Research Mobility Fellowships funding opportunity will open on October, 3rd, 2022. The call aims to support PhD students, postdocs, and medical doctors in training to undertake scientific visits fostering specialist research training outside their…
The ERN Research Training Workshops funding opportunity is now open for applications until October 1st. The goal of the workshops is to train researchers and clinicians affiliated to ERN- Full Members or – Affiliated Partners in relevant topics on research in rare diseases. Training themes may include innovative research methodologies, diagnostic research topics, interdisciplinary treatment approaches, such as gene therapy and transplantation,…
Two webinar videos have just been released on the VASCERN Youtube channel titled The A-Z of Aortic Syndrome in Marfan syndrome and Before and After Aortic Surgery: Q&A for Marfan Patients. These videos are recordings of an informative webinar on Aortic surgery in Marfan syndrome (and other HTADs) held on…
The first five-year evaluation of the ERNs and their HCP Full Members (members that are in the ERNs since 2017) is scheduled to start in September 2022 and finish by the end of August 2023. This evaluation will be part of the new Assessment, Monitoring, Evaluation and Quality Improvement System…
A new collaborative research paper titled Surveillance and monitoring in vascular Ehlers-Danlos syndrome in European Reference Network For Rare Vascular Diseases (VASCERN) was recently published in the European Journal of Medical Genetics as part of the VASCERN Special Issue. It is co-authored by members and affiliated partners of the VASCERN Medium Sized Arteries Working…
The Bring Your Own Omics Data (BYOOD) workshop (17th-18th November 2022) by EJ PRD is aiming to help you to optimize and integrate your omics data, initiate network analysis, and continue collaborations with the data analysis team. In order to help them further understand what your needs on data analysis are, and to adapt the workshop to them please complete…
In our first VASCERN Exchange Program interview, we are thrilled to interview Dr. Ruben Hermann from the CHU de Lyon HCL, GH Est-Hôpital Femme Mère Enfant in Lyon, France. Dr. Ruben Hermann is a member of the Hereditary Haemorrhagic Telangiectasia Working Group (HHT-WG). In this article, he shares what were…
